Newsfeeds - Spark Newswire

4 minute read

55 Biggest Movers From Friday

Today, 2:47 PM

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate strategic alternatives for the Company to maximize shareholder value.

ALVR

25 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 2:47 PM

On Friday =, 431 companies hit new 52-week lows.

AAOI

4 minute read

53 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:47 PM

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum Co. for a digital solution to manage Marine Logistics.

ALVR

3 minute read

Mid-Afternoon Market Update: Dow Jumps Around 300 Points; AlloVir Shares Spike Higher

By Lisa Levin

Today, 2:47 PM

U.S. stocks traded mixed toward the end of trading, with the Dow Jones climbing around 300 points on Wednesday.

ALVR

3 minute read

Mid-Day Market Update: Nasdaq Down Over 150 Points; Netflix Shares Drop Following Earnings Report

By Lisa Levin

Today, 2:47 PM

U.S. stocks traded mixed midway through trading, with the Nasdaq composite dropping more than 150 points on Wednesday.

ALVR

2 minute read

28 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 2:47 PM

Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday.

ALVR

1 minute read

Why AlloVir Stock Is Surging Today

By Adam Eckert

Today, 2:47 PM

AlloVir Inc (NASDAQ: ALVR) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Regenerative Medicine Advanced Therapy designation to its lead investigational multi-virus-specific T cell therapy, posoleucel.

ALVR

2 minute read

The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus’ COVID-19 Vaccine Trial Data, FDA Rejects Teva’s Schizophrenia Med, Otonomy Aces Hearing Loss Study

By Vandana Singh

Today, 2:47 PM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ALVR

6 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 2:47 PM

On Thursday, 92 companies hit new 52-week lows.

ABOS

3 minute read

AlloVir Initiates Global Phase 3 Registrational Study Of Posoleucel For Prevention Of Life-Threatening Viral Infections From Six Common Viruses In High-Risk, Allogeneic Hematopoietic Cell Transplant Patients

By Benzinga Newsdesk

Today, 2:47 PM

AlloVir (NASDAQ:ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced the initiation of a Phase 3 registrational study of posoleucel, an allogeneic, off-the-shelf, multi-virus-specific

ALVR